| Structure | Chemical Name | CAS | MF |
|
1,3-Dioxolo[4,5-c]oxepin-4,7-imine (9CI)
|
140151-87-7
|
C7H5NO3
|
|
2H-Cyclopent[b]isoxazolo[5,4-e]pyridine(9CI)
|
140151-88-8
|
C9H6N2O
|
|
1-allylisoguanosine
|
140156-26-9
|
C13H17N5O5
|
|
1-allylxanthosine
|
140156-27-0
|
|
|
4-METHYL-PENTANOIC ACID HYDRAZIDE
|
140157-44-4
|
C6H14N2O
|
|
4'-azidothymidine 5'-triphosphate
|
140158-13-0
|
C10H16N5O14P3
|
|
hippocampal cholinergic neurostimulating peptide
|
140158-49-2
|
C53H79N13O17
|
|
ATPA
|
140158-50-5
|
C10H16N2O4
|
|
acetyl 2,3-dioxopropanal-di-(4,4-dimethylthiosemicarbazone)
|
140158-63-0
|
C11H20N6O2S2
|
|
N,N-(bis(2-pyridylmethyl)-gamma-aminobutyrato)copper(II)
|
140160-00-5
|
C16H18BrCuN3O2
|
|
1H-Pyrrolo[1,2-c]imidazole-1,3(2H)-dione,tetrahydro-2-hydroxy-,(S)-(9CI)
|
140160-63-0
|
C6H8N2O3
|
|
1,3-Phenylenbis(methoxy-2-benzaldehyde)
|
140160-96-9
|
C22H18O4
|
|
4-fluoroeticlopride
|
140161-12-2
|
C17H24ClFN2O3
|
|
mahmoodin
|
140163-23-1
|
C30H38O8
|
|
bombesin (6-14), D-Trp(6)-Leu(13)-psi(CH2NH)-Leu(14)-
|
140163-54-8
|
C55H79N15O9
|
|
6-iodoclorgyline
|
140163-68-4
|
C13H14Cl2INO
|
|
NBD-COCL
|
140164-85-8
|
C9H7ClN4O4
|
|
ASM 5-67
|
140164-86-9
|
C29H32N6O7
|
|
ASM 5-10
|
140164-88-1
|
C40H43N5O9
|
|
2,2-Azetidinedicarboxylicacid,4-oxo-(9CI)
|
140165-44-2
|
C5H5NO5
|
|
2-Pyrrolidinone,1-(1E)-1-propenyl-(9CI)
|
140165-83-9
|
C7H11NO
|
|
1,3-Benzodioxole, 3a,4,5,7a-tetrahydro-2,2-dimethyl-, (3aR-cis)- (9CI)
|
140169-27-3
|
C9H14O2
|
|
BOC-ASP(OSU)-OBZL
|
140171-25-1
|
C20H24N2O8
|
|
tert-butyl 3-methyl-1-oxobutan-2-ylcarbamate
|
140171-27-3
|
C10H19NO3
|
|
3,5-Hexadien-2-one, 4-methoxy-, (E)- (9CI)
|
140171-39-7
|
C7H10O2
|
|
2,4-Hexanedione, 6-methoxy- (9CI)
|
140171-42-2
|
C7H12O3
|
|
Amlodipine Diethyl Ester
|
140171-65-9
|
C21H27ClN2O5
|
|
Amlodipine Dimethyl Ester
|
140171-66-0
|
C19H23ClN2O5
|
|
Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, [S-(R*,R*)]-, (E)-2-butenedioate (2:1) (salt)
|
140173-32-6
|
C23H28N2O8
|
|
Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, [R-(R*,S*)]-, (E)-2-butenedioate (2:1) (salt)
|
140173-34-8
|
C23H28N2O8
|
|
N,N-Dimethyl 4-formyl-1H-imidazole-1-sulfonamide
|
140174-48-7
|
C6H9N3O3S
|
|
lyxo-2-Octulose, 3,5:4,8-dianhydro-1,6,7-trideoxy- (9CI)
|
140174-63-6
|
C8H12O3
|
|
4-Oxo-1,3-piperidinedicarboxylic acid
|
140176-27-8
|
C7H9NO5
|
|
4-methyl-4,5-secocholestane
|
140183-68-2
|
C28H52
|
|
(S)-(-)-5-FLUOROWILLARDIINE
|
140187-23-1
|
C7H8FN3O4
|
|
5-chlorowillardiine
|
140187-24-2
|
C7H8ClN3O4
|
|
(S)-(-)-5-IODOWILLARDIINE
|
140187-25-3
|
C7H8IN3O4
|
|
Remurin A
|
140187-44-6
|
C48H34O31
|
|
naltrexone-estrone azine
|
140188-23-4
|
C38H45N3O4
|
|
L-Alanine, monoanhydride with boric acid (H3BO3) (9CI)
|
140189-20-4
|
C3H8BNO4
|
|
1H-Imidazo[4,5-f]isoquinoline,2-methyl-(9CI)
|
140192-87-6
|
C11H9N3
|
|
5,6-Isoquinolinediamine
|
140192-89-8
|
C9H9N3
|
|
Triptorelin acetate
|
140194-24-7
|
C64H82N18O13.C2H4O2
|
|
ethyl 3,4-dioxobutyrate-di-(4,4-dimethylthiosemicarbazone)
|
140197-70-2
|
C12H22N6O2S2
|
|
4-[[1-[4-[[(1R)-1-[[(1S)-4-(acetyl-hydroxy-amino)-1-[[(2R)-2-[[(2S,3R) -2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydro xy-propanoyl]carbamoyl]butyl]-(1-hydroxy-2-oxo-3-piperidyl)carbamoyl]e thyl]carbamoyl]-3,4,5,6-tetrahydropyrimidin-2-yl]-2-(4-hydroxyphenyl)e thyl]carbamoyl]-2-amino-butanoic acid
|
140198-04-5
|
C46H73N13O16
|
|
Carbamic acid, (1-methyl-2-butenyl)-, 1,1-dimethylethyl ester, [S-(Z)]- (9CI)
|
140199-89-9
|
C10H19NO2
|
|
PENTAFLUOROPHENYL 2,3,4,5,6-PENTAFLUORO-BENZENESULFONATE
|
140200-31-3
|
C12F10O3S
|
|
1,5-DIBROMO-PENTAN-3-ONE
|
140200-76-6
|
C5H8Br2O
|
|
Pyrimidine, 2-(1,1-dimethylethyl)-4-methoxy- (9CI)
|
140201-04-3
|
C9H14N2O
|
|
HW 162
|
140201-07-6
|
C14H20BrNO
|
|
1,4-dihydrotrigonelline
|
140201-08-7
|
C7H9NO2
|
|
CHEMPACIFIC 36181
|
140201-11-2
|
C23H39NO3S
|
|
Trifluoro-methanesulfonic acid isoquinolin-5-yl ester
|
140202-00-2
|
C10H6F3NO3S
|
|
AC-DL-PHE(4-BR)-OET
|
140202-28-4
|
C13H16BrNO3
|
|
3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline
|
140202-46-6
|
|
|
2H-Oxireno[3,4]cyclopenta[1,2-c]pyridine(9CI)
|
140203-54-9
|
C8H5NO
|
|
Formaldehyde, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, 4-(1,1-dimethylethyl)phenol, 1,3-isobenzofurandione, 4,4-(1-methylethylidene)bisphenol and 1,2,3-propanetriol, benzoate octadecadienoate (9Z,12Z)-9,12-octadecadienoate
|
140204-23-5
|
C18H32O2.xC18H32O2.x(C15H16O2.C10H14O.C8H4O3.C5H12O4.C3H8O3.CH2O)x.xC7H6O2
|
|
|
mucoric acid
|
140207-84-7
|
|
|
|
Pentosan
|
140207-93-8
|
|
|
|
thymosin beta(12)
|
140208-13-5
|
|
|
|
oxygen-evolving complex, 23 kDa precursor
|
140208-15-7
|
|
|
|
HUMAN PAI-1
|
140208-23-7
|
|
|
Cyclopentanecarboxylic acid, 3-isocyanato-, (1R-cis)- (9CI)
|
140210-16-8
|
C7H9NO3
|
|
Bicyclo[4.2.0]octa-1,3,5-trien-7-one, 4-(1-methylethyl)- (9CI)
|
140210-31-7
|
C11H12O
|
|
2',3'-dideoxyadenylosuccinate
|
140210-37-3
|
C14H18N5O9P
|
|
Cyclopentane-1,2-dione, 3,3,5,5-tetramethyl-, bis(o-methyloxime)-, (E, E)-
|
140210-44-2
|
C11H20N2O2
|
|
Ethanone, 1-(4,5-diethyl-4,5-dihydro-3-isoxazolyl)-, trans- (9CI)
|
140210-49-7
|
C9H15NO2
|
|
4-(2-methoxycarbonimidoylethyl)phenyl 10-methyacridinium-9-carboxylate
|
140210-82-8
|
C25H24Cl2N2O3
|
|
Pyrimidine, 4-(1-aziridinyl)- (9CI)
|
140212-80-2
|
C6H7N3
|
|
3-(2,6-dioxopiperidin-1-yl)benzoic acid
|
140213-08-7
|
C12H11NO4
|
|
ethyl 2-(3-(broMoMethyl)phenyl)acetate
|
140215-42-5
|
C11H13BrO2
|
|
But-3-en-2-one, 4-phenylamino-3-(1-phenyl-5-tetrazolyl)-
|
140215-50-5
|
C17H15N5O
|
|
N-BUTYL-N'-HYDROXY-GUANIDINE
|
140215-98-1
|
C5H13N3O
|
|
6-Hydroxy-1,1-dioxo-1l6-[1,4]thiazepane-4-carboxylic acid tert-butyl ester
|
140217-83-0
|
C10H19NO5S
|
|
tert-butyl 6-oxo-1,4-thiazepane-4-carboxylate 1,1-dioxide
|
140217-84-1
|
C10H17NO5S
|
|
1,2-diheptadecanoyl-sn-glycero-3-phosphoethanolaMine
|
140219-78-9
|
C39H78NO8P
|
|
Phenol, 2-fluoro-4-(methylthio)-
|
140220-05-9
|
C7H7FOS
|
|
1,3-BIS[(ACRYLOXYMETHYL)PHENETHYL]TETRAMETHYLDISILOXANE
|
140220-31-1
|
C28H38O5Si2
|
|
8-acetyl-2-(dipropylamino)tetralin
|
140221-50-7
|
C18H27NO
|
|
(4E,18E)-3',4',5',6'-Tetrahydro-7,9,11-trihydroxy-6'-(2-hydroxybutyl)-5',6,8,12,27-pentamethyl-20-(2-methylpropyl)spiro[2,24-dioxabicyclo[21.3.1]heptacosa-4,18-diene-25,2'-[2H]pyran]-3,21-dione
|
140221-72-3
|
C42H72O9
|
|
(4E,18E)-3',4',5',6'-Tetrahydro-7,9,11,12-tetrahydroxy-6'-(2-hydroxybutyl)-5',6,8,12,27-pentamethyl-20-(2-methylpropyl)spiro[2,24-dioxabicyclo[21.3.1]heptacosa-4,18-diene-25,2'-[2H]pyran]-3,21-dione
|
140221-73-4
|
C42H72O10
|
|
3-(4'-Carboxyphenyl)iMino-3H-phenothiazine
|
140222-07-7
|
C19H12N2O2S
|
|
4-O-allylxylopyranose
|
140222-17-9
|
|
|
2-(trimethylsilyl)ethyl O-(2,3-di-O-benzylxylopyranosyl)(1-4)-O-(2,3-di-O-benzoylxylopyranosyl)-(1-4)-O-(2,3-di-O-benzylxylopyranosyl)-(1-4)-2,3-di-O-benzoylxylopyranoside
|
140222-29-3
|
C81H86O21Si
|
|
2-(trimethylsilyl)ethyl-O-(2,3-di-O-benzylxylopyranosyl)-(1-4)-bis(O-(2,3-di-O-benzoylxylopyranosyl)-(1-4)-(2,3-di-O-benzylxylopyranosyl)-(1-4))-2,3-di-O-benzoylxylopyranoside
|
140222-31-7
|
C119H122O31Si
|
|
1,2,3,4-Tetra-O-benzoyl-L-fucopyranose
|
140223-15-0
|
C34H28O9
|
|
trilobacin
|
140224-67-5
|
C37H66O7
|
|
S-(3-oxopropyl)-N-acetylcysteine
|
140226-30-8
|
|
|
4-MERCAPTO-4-METHYLVALERIC ACID
|
140231-31-8
|
C6H12O2S
|
|
leucasin
|
140231-39-6
|
C42H70O12
|
|
esculentagenin
|
140231-40-9
|
C31H46O8
|
|
4-carboxymethylphenylalanine
|
140233-60-9
|
C11H13NO4
|
|
N-(3-Amino-2,4,6-trinitrophenyl)-2,4,6-trinitro-1,3-benzenediamine
|
140233-87-0
|
C12H7N9O12
|
|
valproyl-adenylic acid
|
140233-88-1
|
|
|
albumin blue 670
|
140234-15-7
|
C23H22Cl2N5O+
|
|
S-D-dithiomandeloylglutathione
|
140234-19-1
|
C18H23N3O7S2
|
|
rac (2,3-Dimethoxyphenyl)-4-piperidinemethanol
|
140235-25-2
|
C14H21NO3
|
|
(3,4-DIFLUORO-PHENYL)-PIPERIDIN-4-YL-METHANONE HYDROCHLORIDE
|
140235-26-3
|
C12H14ClF2NO
|
|
2-HYDROXYSUCCINIC ACID METHYL ESTER
|
140235-34-3
|
C5H8O5
|
|
ETHYL (3R,5S)-6-HYDROXY-3,5-O-ISO-PROPYLIDENE-3,5-DIHYDROXYHEXANOATE
|
140235-40-1
|
C11H20O5
|